KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Free Cash Flow (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 -73.23%
Dec 28, 2025 -31.70%
Sep 28, 2025 182.61%
Jun 29, 2025 -16.10%
Mar 30, 2025 -37.09%
Dec 29, 2024 -22.87%
Sep 29, 2024 49.54%
Jun 30, 2024 63.40%
Mar 31, 2024 -54.57%
Dec 31, 2023 -3.80%
Oct 1, 2023 113.28%
Jul 2, 2023 27.74%
Apr 2, 2023 37.27%
Oct 3, 2021 67.58%
Jul 4, 2021 32.50%
Apr 4, 2021 -51.61%
Jan 3, 2021 -8.19%
Sep 27, 2020 174.05%
Jun 28, 2020 2.09%
Mar 29, 2020 -46.81%
Dec 29, 2019 -24.24%
Sep 29, 2019 32.69%
Jun 30, 2019 77.03%
Mar 31, 2019 -41.39%
Dec 30, 2018 -9.66%
Sep 30, 2018 4.78%
Jul 1, 2018 76.53%
Apr 1, 2018 -39.40%
Dec 31, 2017 -11.16%
Oct 1, 2017 7.73%
Jul 2, 2017 116.02%
Apr 2, 2017 -25.40%
Sep 27, 2015 13.68%
Jun 28, 2015 102.10%
Mar 29, 2015 -25.06%
Dec 28, 2014 -20.37%
Sep 28, 2014 -16.82%
Jun 29, 2014 42.48%
Mar 30, 2014 21.51%
Dec 29, 2013 -47.26%
Sep 29, 2013 20.05%
Jun 30, 2013 153.10%
Mar 31, 2013 -23.97%
Dec 30, 2012 -48.26%
Sep 30, 2012 17.85%
Jul 1, 2012 59.05%
Apr 1, 2012 752.42%
Oct 3, 2010 35.03%
Jul 4, 2010 1.34%
Apr 4, 2010 -25.88%
Jan 3, 2010 -2.89%
Sep 27, 2009 63.63%
Jun 28, 2009 16.89%